HempFusion Wellness Inc. (TSX:CBD.U) (US:CBDHF) (FWB:8OO)
(“HempFusion” or the “Company”), a leading health and wellness
Company offering premium probiotic supplements and products
containing CBD, is pleased to announce following its launch of
Probulin Probiotics on Alibaba Group Holding’s Tmall Global
(“Tmall”), it has now received conditional approval to launch
HempFusion’s CBD products on Tmall, the world’s largest cross
border online marketplace reaching more than 750 million potential
new consumers across mainland China, Hong Kong, Macau and
Taiwan.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20210406005360/en/
(Graphic: Business Wire)
“We are incredibly excited to receive approval for HempFusion’s
flagship store from Tmall, joining our subsidiary, Probulin
Probiotics, on China’s leading eCommerce platform reaching the
world’s largest consumer base,” said Jon Visser, HempFusion’s Chief
Revenue Officer. “To be one of the first publicly traded CBD
companies on the platform provides us with significant competitive
advantages that have the potential to add considerable revenue to
our Company,’’ continued Mr. Visser.
HempFusion’s topicals with CBD are expected to launch on Tmall
soon and will include its OTC drug listed Acne Relief, Eczema
Relief, and Sports Relief Creams, Pain Relief and Sports Pain
Relief Balms, Pain Relief Gel and Wound Ointment, with more
products expected to follow. These unique formulations include a
proprietary skin nourishing and moisturizing base with Aloe Vera,
Shea butter, Jojoba oil, Hemp derived omega fatty acids and CBD, as
well as many other botanicals.
“Building on our established relationship with the Alibaba Group
and Tmall, and introducing our premium HempFusion OTC Drug Listed
Topical products throughout this premier Asian eCommerce platform,
has been a major focus of our strategic expansion plan,” stated
Jason Mitchell, N.D., HempFusion’s Co-Founder and CEO. “We are now
accessing one of the largest online consumer groups in the world
with products formulated with approved drug monograph ingredients
such as menthol for ailments such as pain. These products have
already performed as best in class in select retailers in the
United States, and we’re excited to see that follow through in the
world’s largest market,” continued Dr. Mitchell.
Tmall, the third most visited website in the world, provides
unique opportunities to raise brand awareness and drive conversions
through comprehensive digital marketing campaigns, including
shoppable live streams with product demonstrations and special
offers. Brand hosts drive traffic through live, digital
interaction, resulting in more engaged consumers staying tuned in
longer.
“Our highest profile influencers are looking forward to engaging
with the enormous Asian market through this live stream eCommerce
format,” stated Mr. Visser. “They’ll deliver authentic,
first-person testimonials and experiences, interacting and
educating new consumers on the many wellness benefits of HempFusion
products,” continued Mr. Visser.
HempFusion is ranked #2 in brand awareness according to a recent
survey conducted by Brightfield Group. “Our goal is to achieve the
same brand awareness and reach that top spot in Greater China,”
added Dr. Mitchell.
ABOUT HEMPFUSION
HempFusion is a leading health and wellness CBD company
utilizing the power of whole-food hemp nutrition. HempFusion
distributes its family of brands, including HempFusion, Probulin
Probiotics, Biome Research, and HF Labs, to approximately 4,000
retail locations across all 50 states of the United States and
select international locations. Built on a foundation of regulatory
compliance and human safety, HempFusion’s diverse product portfolio
comprises 48 SKUs including tinctures, proprietary FDA Drug Listed
Over-The-Counter (OTC) Topicals, Doctor/Practitioner Lines and
more. With a strong focus on research and development, HempFusion
has an additional 30 products under development. HempFusion is a
board member of the US Hemp Roundtable, and HempFusion’s
wholly-owned subsidiary, Probulin Probiotics, is one of the
fastest-growing probiotics companies in the United States,
according to SPINs reported data. HempFusion’s CBD products are
based on a proprietary Whole Food Hemp Complex™ and are available
in-store or by visiting HempFusion online at www.hempfusion.com or
www.probulin.com.
Follow HempFusion on Twitter, Facebook and Instagram and
Probulin on Twitter, Facebook and Instagram.
FORWARD-LOOKING STATEMENTS
This news release contains forward-looking statements and
forward-looking information within the meaning of Canadian
securities legislation (collectively, “forward-looking
statements“) that relate to HempFusion’s current expectations
and views of future events. Any statements that express, or involve
discussions as to, expectations, beliefs, plans, objectives,
assumptions or future events or performance (often, but not always,
through the use of words or phrases such as “will likely result”,
“are expected to”, “expects”, “will continue”, “is anticipated”,
“anticipates”, “believes”, “estimated”, “intends”, “plans”,
“forecast”, “projection”, “strategy”, “objective” and “outlook”)
are not historical facts and may be forward-looking statements and
may involve estimates, assumptions and uncertainties which could
cause actual results or outcomes to differ materially from those
expressed in such forward-looking statements. No assurance can be
given that these expectations will prove to be correct and such
forward-looking statements included in this news release should not
be unduly relied upon. These statements speak only as of the date
of this news release. In particular and without limitation, this
news release contains forward-looking statements relating to the
launch of the Company’s CBD products on Tmall and the timing and
revenue opportunity thereof, planned launch of the Company’s
additional brands in Greater China, the Company’s marketing and
strategic expansion plans and the Company’s other plans, focus and
objectives.
Forward-looking statements are based on a number of assumptions
and are subject to a number of risks and uncertainties, many of
which are beyond HempFusion’s control, which could cause actual
results and events to differ materially from those that are
disclosed in or implied by such forward-looking statements. Such
risks and uncertainties include, but are not limited to, the impact
and progression of the COVID-19 pandemic and other factors set
forth under “Cautionary Note Regarding Forward Looking Statements”
and “Risk Factors” in the annual information form of the Company
dated March 31, 2021 and available under the Company’s profile on
SEDAR at www.sedar.com. HempFusion undertakes no obligation to
update or revise any forward-looking statements, whether as a
result of new information, future events or otherwise, except as
may be required by law. New factors emerge from time to time, and
it is not possible for HempFusion to predict all of them or assess
the impact of each such factor or the extent to which any factor,
or combination of factors, may cause results to differ materially
from those contained in any forward-looking statement. Any
forward-looking statements contained in this news release are
expressly qualified in their entirety by this cautionary
statement.
Neither the TSX nor its Regulation Services Provider (as that
term is defined in the policies of the TSX) accepts responsibility
for the adequacy or accuracy of this release.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210406005360/en/
Jason Mitchell, N.D. Chief Executive Officer and Director Email:
ir@hempfusion.com Phone: 416-803-5638
HempFusion Wellness (TSX:CBD.U)
Historical Stock Chart
From Apr 2024 to May 2024
HempFusion Wellness (TSX:CBD.U)
Historical Stock Chart
From May 2023 to May 2024